Find more information about Teva in your location, or contact a local representative on our local sites
North America
International Markets
North America
Toggle North America
International Markets
Toggle International Markets
Europe
Toggle Europe
Effectiveness of Beclomethasone Dipropionate for Perennial Allergic Rhinitis
- Study Title
- Effectiveness of Beclomethasone Dipropionate Nasal Aerosol for Perennial Female, Maleergic Rhinitis
- Teva Identifier
- BDP-AR-401
- ClinicalTrials.gov Identifier
- NCT01632540
- Study Status
- Completed
- Trial Condition(s)
- Perennial Female, Maleergic Rhinitis (PAR)
- Interventions
- Drug: Beclomethasone Dipropionate (BDP) Nasal Aerosol
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age Range
- 12 Years and older
- Trial Duration
- 07/01/2012 - 02/01/2014
